Fig. 7
Increased EIF4G1 mRNA expression was associated with lower median survival in cancer patients: Survival probability based on EIF4G1 mRNA expression was performed through UALCAN web server. Analysis of survival data revealed that Brain lower grade glioma, kidney, liver, lung, mesothelioma, pancreatic, prostate cancer, sarcoma, and skin cutaneous melanoma patients with high EIF4G1 expression had lower median survival compared to the patient with low/Medium EIF4G1 expression (a–i)